Career for Pharm.D as Clinical Research Coordinator at Nizams Institute of Medical Sciences
A Prospective, Multicenter, Single-arm, Open-label, Phase IV, Post authorization Interventional Study to Assess the Safety and Efficacy of Asciminib in Indian Patients with Ph+ CML-CP without T315I Mutation, Previously Treated with two or more Tyrosine Kinase Inhibitors and Ph+ CML-CP with T315I Mutation
